Brite Health

Patient-First Technology for Engagement
in Clinical Trials and Beyond the Pill


Distribute

Remotely


Engage Patients

& Avoid Dropouts


Reveal Data

& Actionable Insights


Complete Trials

On Schedule

Patient Dropouts

As many as 40% of Phase III trial subjects become disengaged and drop out of the study. This delay risks trial timelines and increases the costs. Sponsors could face as much as $8M in lost revenue, for each day their drugs are delayed. Patient disengagement and dropouts is the main contributor to these costly delays.

Patient Engagement

Brite Engage offers a patient-first mobile platform powered by its proprietary data-driven engine to improve engagement in clinical trials. Key engaging features include personalized and effective communication between patients and site staff, as well as relevant content specific to the therapeutic area. ​

Global

Footprint

HIPAA

Compliant

24/7

Support

Translation

Support

Proprietary Features

sign up for Brite Health's newsletter